OnKure Therapeutics, Inc.

Total Valuation

OnKure Therapeutics, Inc. carries a market capitalization of 57.43M, placing it among publicly traded companies globally. Its enterprise value stands at -135.48M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Share Statistics

OnKure Therapeutics, Inc. currently has 41.08M shares outstanding.

Valuation Ratios

Financial Position

OnKure Therapeutics, Inc. maintains a current ratio of 13.78, meaning it holds 13.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 0.22, indicating conservative leverage, while an interest coverage ratio of -7,593.00 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Stock Price Statistics

OnKure Therapeutics, Inc.'s stock has gained approximately 56.13383% over the past 52 weeks. The 50-day moving average sits at 4.25, while the 200-day moving average is 3.24.

Income Statement

EBITDA reached -60.74M, while operating income came in at -61.56M.

Balance Sheet

OnKure Therapeutics, Inc. holds 192.11M in cash and equivalents against 409,000.00 in total debt, resulting in a net debt position of -192.11M. Total book value stands at -229.39M, with working capital of 183.15M providing operational flexibility.

Cash Flow

OnKure Therapeutics, Inc. produced -50.76M in operating cash flow over the past twelve months. After subtracting -33,000.00 in capital expenditures, free cash flow totaled -50.79M - equivalent to -3.74 per share.

Dividends & Yields

Stock Splits

OnKure Therapeutics, Inc.'s most recent stock split took place on October 7, 2024 with a 10:1 split ratio.

Scores

OnKure Therapeutics, Inc. posts an Altman Z-Score of 0.82, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.